Pure Global
PACTR202310849449401

Use of Sildenafil Citrate in the Management of Unexplained Infertility in Kisangani, Democratic Republic of Congo

Clomiphene citrate and Sildenafil citrate versus Clomiphene citrate and Estradiol valerate for Induction of ovulation in congolese patient with unexpalined infertility: A Randomised Controlled Trial.
FONDATION DES ANGES·Phase 3·Pan Africa Clinical Trials Registry·drugRecruitment Completed
Study focus
Disease/Condition
Obstetrics and Gynecology
Intervention type
drug
Sponsor & location
Primary sponsor
FONDATION DES ANGES
Funder
University of Kisangani
Location
Democratic Republic of the Congo
Timeline & enrollment
Phase
Phase 3
Start date
Oct 01, 2021
End date
Jan 01, 1900
Summary

Traditionally, the diagnosis of unexplained infertility is made when the standard aetiological work-up has failed to reveal any abnormality. For this reason, treatment is typically empirical. first line treatment of unexplained infertility includes observation of the expectant state with timed intercourse and life changes, or clomiphene citrate and intra uterine insemination. In Africa, the most infertile couples do not accept to observe the expectant state. This study aims to evaluate the effectiveness and the safety of Clomiphene citrate + Sildenafil citrate compared with Clomiphene citrate + Estradiol valerate in inducing ovulation in congolese patients suffering from unexplained infertility.

ICD-10 classifications
Obstetric and gynaecological devices associated with adverse incidentsObstructed labour due to other maternal pelvic abnormalitiesObstetric and gynaecological devices associated with adverse incidents : miscellaneous devices, not elsewhere classifiedObstetric and gynaecological devices associated with adverse incidents : diagnostic and monitoring devicesOther complications of obstetric surgery and procedures
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202310849449401
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202310849449401 through Pure Global AI's free database. This Phase 3 trial is sponsored by FONDATION DES ANGES and is currently Recruitment Completed. The study focuses on Obstetrics and Gynecology.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.